These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3494907)

  • 1. Natural killer cells do not lyse resting or mitogen-stimulated B cells.
    Froelich CJ; Guiffaut S
    Nat Immun Cell Growth Regul; 1987; 6(1):12-8. PubMed ID: 3494907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
    Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of proliferation in vitro of resting human natural killer cells: expression of surface activation antigens.
    London L; Perussia B; Trinchieri G
    J Immunol; 1985 Feb; 134(2):718-27. PubMed ID: 3917474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural killer cells lysing the blood B-lymphocytes of patients with chronic lympholeukemia].
    Khonina NA; Shubinskiĭ GZ
    Eksp Onkol; 1988; 10(4):44-6. PubMed ID: 3263265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
    Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT
    J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of natural killer and interleukin-2 activated killer cell activity in ataxia-telangiectasia with T cell deficiency.
    Tsuge I; Matsuoka H; Torii S; Okada J; Mizuno T; Matsuoka M; Kodera Y; Takahashi T
    J Clin Lab Immunol; 1987 May; 23(1):7-13. PubMed ID: 3497277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogenicity of fetal calf serum.
    Gergely P; Bakács T
    Haematologia (Budap); 1977; 11(3-4):259-63. PubMed ID: 311308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
    Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
    Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Gc (vitamin-D binding protein) with membrane of activated natural cytolytic cells.
    Ades EW; Bosse D; Nicholson JK; Galbraith R
    Tokai J Exp Clin Med; 1988 Dec; 13(6):293-7. PubMed ID: 3273473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and functional analyses of tumour-infiltrating Leu 7 + natural killer-like cells in non-Hodgkin lymphomas.
    Banerjee D
    Cancer Detect Prev Suppl; 1987; 1():103-9. PubMed ID: 3500777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y; Levanon M; Davidsohn J; Ramot B
    J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens.
    Dao T; Gomez-Nunez M; Antczak C; Kappel B; Jaggi JS; Korontsvit T; Zakhaleva V; Scheinberg DA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8763-72. PubMed ID: 16361564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthyroxinemic mice have reduced natural killer cell activity. Evidence for a defective trigger mechanism.
    Stein-Streilein J; Zakarija M; Papic M; McKenzie JM
    J Immunol; 1987 Oct; 139(7):2502-7. PubMed ID: 3498760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.
    Kogure T; Mantani N; Goto H; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2002 Aug; 11(4):219-24. PubMed ID: 12396473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.